Confined or spread disease-Spread with distant metastasis Page 2 Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread with distant metastasis Posts on Medivizor

Looking for participants to test a new vaccine to treat advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and toxicity of PolyPEPI1018 vaccine in the treatment of advanced colorectal cancer. The main outcome to be measured is tumor response to the treatment. This trial will be conducted in Italy, and Minnesota, US. The details The standard treatment for metastatic (spread to other parts of the body)...

Read More

Looking for participants to test a new treatment combination for advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of treatment with nivolumab (Opdivo) and relatlimab in patients with advanced colorectal cancer. The main outcome to be measured will be tumor response to the treatment. This trial is being conducted in Maryland, US. The details Colorectal cancer is the third most common cancer in the...

Read More

Looking for participants with colorectal cancer and liver metastasis to test a new cancer vaccine

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of mFOLFOX6 (oxaliplatin, leucovorin, fluorouracil) and nivolumab (Opdivo) with and without a new cancer vaccine (CV301) for patients with colorectal cancer that has spread to the liver. The main outcome will be overall survival. This trial is being conducted in California and New Jersey,...

Read More

Looking for participants with metastatic colorectal cancer to try a new treatment combination

Posted by on Mar 26, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is comparing the effectiveness and toxicity of ABT-165 or bevacizumab (Avastin) plus FOLFIRI (irinotecan, leucovorin, fluorouracil) chemotherapy in patients with metastatic (spread to other parts of the body) colorectal cancer. The main outcome to be measured will be tumor response and survival without cancer...

Read More

Looking for participants to test the effectiveness and safety of vicriviroc in the treatment of advanced colorectal cancer

Posted by on Mar 12, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of vicriviroc (VIC) plus pembrolizumab (Keytruda) in the treatment of advanced colorectal cancer. The main outcome to be measured is the tumor response to treatment. This trial is being conducted in the US and Canada.   The details Colorectal cancer is the third most common...

Read More

Olaparib for treating breast cancer that has spread

Posted by on Mar 5, 2019 in Breast cancer | 0 comments

In a nutshell This study determined whether treating breast cancer that has spread (metastatic) with olaparib (Lynparza) resulted in better outcomes and fewer side effects compared to chemotherapy. The study found that treatment with olaparib led to similar survival outcomes compared to chemotherapy.  Some background There are...

Read More

Looking for participants with advanced colorectal cancer to test a new cancer vaccine

Posted by on Feb 27, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness of a new cancer vaccine. The main outcomes to be measured are cancer response and side effects. This trial is recruiting in New York and Tennessee, US. The details The standard treatment for most cancers is surgery and chemotherapy. However, chemotherapy has a limited effectiveness and a high...

Read More

Searching for patients with untreated advanced melanoma to trial a new personalized cancer vaccine

Posted by on Feb 23, 2019 in Melanoma | 0 comments

In a nutshell This trial aims to see if combining two medications, pembrolizumab (Keytruda) and RO7198457 (a new experimental vaccine) is better than just using pembrolizumab in treating advanced melanoma that has not been treated before. The main outcome that will be measured is how long the patients go without cancer growing. The study is being...

Read More